Novo Nordisk stock falls after soft Wegovy pill sales dull guidance lift
Why it matters: Investors remain focused on price pressure, pipeline doubts and intensifying competition from Eli Lilly.
Bloomberg, CNBC +2
Subject
#Wegovy
Novo Nordisk sues Eli Lilly over GLP-1 ads in U.S. court
What's next: Novo plans to seek an injunction and wants Lilly to pull the ads, run corrections and pay damages.
BBC News (US & Canada), CNBC +3